Commit To Purchase Galectin Therapeutics At $2.50, Earn 22.8% Annualized Using Options
April 07, 2015 at 13:20 PM EDT
Investors considering a purchase of Galectin Therapeutics Inc (GALT) stock, but tentative about paying the going market price of $3.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $2.50 strike, which has a bid at the time of this writing of 30 cents..